Resolute Advisors LLC Bristol Myers Squibb CO Transaction History

Resolute Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $31,909 - $37,199	-595 Closed	0 $0
Q2 2021 Dec 27, 2021	BUY	$61.91 - $67.42 $36,836 - $40,114	595 New	595 $40,000
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $36,836 - $40,114	-595 Closed	0 $0
Q1 2021 Dec 27, 2021	BUY	$59.34 - $66.74 $35,307 - $39,710	595 New	595 $25,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Resolute Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Resolute Advisors LLC with notifications on news.